Pluvo | $5,000,000 | (Mar 3, 2026)
Flux(US) | $27,000,000 | (Mar 3, 2026)
Multitude Insights | $10,000,000 | (Mar 3, 2026)
Certified by Founder
Lodge
Lassen Therapeutics
start up
United States
- San Diego, California
- 21/12/2023
- Series B
- $85,000,000
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
- Industry Biotechnology Research
- Website https://lassentherapeutics.com/
- LinkedIn https://www.linkedin.com/company/lassen-therapeutics/
Plurio by Elly Analytics | $3,500,000 | (Mar 3, 2026)
Huper Corporation | $1,500,000 | (Mar 3, 2026)
MeltPlan | $10,000,000 | (Mar 3, 2026)
Inhouse | $5,000,000 | (Mar 3, 2026)
Procode AI | $4,000,000 | (Mar 3, 2026)
Temple | $54,000,000 | (Mar 3, 2026)
SECONDSENSE | $2,000,000 | (Mar 3, 2026)
Ease Health | $41,000,000 | (Mar 3, 2026)
Smack Technologies Inc. | $32,000,000 | (Mar 3, 2026)